111 – 120 of 145
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Performance of two relatively new quantitative D-dimer assays (Innovance D-dimer and AxSYM D-dimer) for the exclusion of deep vein thrombosis.
(
- Contribution to journal › Article
-
Mark
Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
(
- Contribution to journal › Article
-
Mark
Three-Year Survival and Stroke Recurrence Rates in Patients With Primary Intracerebral Hemorrhage.
(
- Contribution to journal › Article
-
Mark
Trombocytopeni kan vara HIT. Heparinbehandling kan ge livshotande låga trombocytvärden
(
- Contribution to journal › Article
- 2008
-
Mark
Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis
(
- Contribution to journal › Article
-
Mark
Epidemiology, risk and prognostic factors in mesenteric venous thrombosis.
(
- Contribution to journal › Article
-
Mark
The Factor V Leiden mutation is associated with a higher blood haemoglobin concentration in women below 50 of the Malmö Thrombophilia Study (MATS).
(
- Contribution to journal › Article
-
Mark
Blödningstidsbestämning har spelat ut sin roll. Otillförlitlig metod som inte längre bör användas i rutinsjukvården
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
(
- Contribution to journal › Article
-
Mark
Evidens för trombosprofylax till medicinpatienter med hög risk
(
- Contribution to journal › Article